Active pharmaceutical ingredient for the manufacture of vaccines.
250 mL Bottle
Its use is recommended in people from 15 years of age, whose occupational profile exposes them to risks of acquiring the disease.
For active immunization against meningococcal disease caused by serogroups A and C, in adults and children from two years of age.
It is recommended for the prevention of tetanus in all ages.
Prevents typhoid fever in adults and children over 2 years of age.
Indicated for the prevention of tetanus and diphtheria in adults, adolescents and children from 7 years of age.
It is indicated for the prevention of tetanus, diphtheria and pertussis in infants and children.
Effective to prevent tetanus and diphtheria if a complete and appropriate vaccination is achieved.
For active immunization against meningococcal disease caused by serogroups B and C.
Clinical trials.
I+D
Clinical trials.
I+D
Active pharmaceutical ingredient for the manufacture of vaccines.
250 mL Bottle
Active pharmaceutical ingredient for the manufacture of vaccines.
250 mL Bottle
Active pharmaceutical ingredient for the manufacture of vaccines.
250 mL Bottle
Active pharmaceutical ingredient for the manufacture of vaccines.
2L Bottle
Active pharmaceutical ingredient for the manufacture of vaccines.
2L Bottle
Active pharmaceutical ingredient for the manufacture of vaccines.
2L Bottle
Active pharmaceutical ingredient for the manufacture of vaccines.
250 mL Bottle
Active pharmaceutical ingredient for vaccine manufacturing.
500 mL Bottle